Literature DB >> 7727475

Abdominal complications after lung transplantation.

P C Smith1, M S Slaughter, M G Petty, S J Shumway, V R Kshettry, R M Bolman.   

Abstract

BACKGROUND: Serious abdominal complications after heart and heart-lung transplantation have been a well-documented source of morbidity and mortality in this patient population. This report reviews the incidence and spectrum of abdominal complications occurring in lung transplant recipients at a single institution.
METHOD: Between January 1988 and July 1993, 75 patients underwent lung transplantation (58 single lung, 16 bilateral single lung, and 1 double lung) at the University of Minnesota.
RESULTS: Twelve patients (16%) sustained 20 abdominal complications. There were 11 early abdominal complications (< or = 30 days after transplantation) including prolonged adynamic ileus (4), diaphragmatic hernia after omental wrap (3), ischemic bowel (2), colitis with hemorrhage (1), and splenic injury after colonoscopy (1). There were nine late abdominal complications (range, 32 days to 28 months after transplantation) including colonic perforation (4), cholelithiasis/choledocholithiasis (2), development of a mesenteric pseudoaneurysm (1), fungal hepatic abscess (1), and intraabdominal hemorrhage (1). Twenty-six procedures were performed for management of the abdominal complications including: colonoscopy (7), colectomy (5), repair of diaphragmatic hernia (3), colostomy takedown (4), small-bowel resection (2), open cholecystectomy with common bile duct exploration (1), open cholecystectomy (1), splenectomy (1), mesenteric arterial pseudoaneurysm embolization (1), and percutaneous liver biopsy (1). Four patients died of causes attributable to their abdominal complications.
CONCLUSIONS: In each case in which a death occurred, there was a delay between the onset of symptoms and diagnosis and intervention of more than 6 days. Abdominal complications accounted for 22% of all deaths in our lung transplantation group. A high index of suspicion and early recognition and intervention will decrease the morbidity and mortality caused by abdominal complications in lung transplant patients.

Entities:  

Mesh:

Year:  1995        PMID: 7727475

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Sepsis in the severely immunocompromised patient.

Authors:  Andre C Kalil; Steven M Opal
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

2.  Incidence and outcome of abdominal surgical interventions following lung transplantation--a single center experience.

Authors:  Kai Timrott; Florian W R Vondran; Mark D Jaeger; Jens Gottlieb; Juergen Klempnauer; Thomas Becker
Journal:  Langenbecks Arch Surg       Date:  2011-03-12       Impact factor: 3.445

3.  Association between diverticular disease requiring surgical intervention and mortality in the postlung transplant population - a retrospective cohort study.

Authors:  Laneshia K Tague; William Adams; Katherine A Young; Oh Jin Kwon; Erin Mahoney; Erin M Lowery
Journal:  Transpl Int       Date:  2019-03-25       Impact factor: 3.782

4.  Greater survival despite increased complication rates following lung transplant for alpha-1-antitrypsin deficiency compared to chronic obstructive pulmonary disease.

Authors:  John R Spratt; Roland Z Brown; Kyle Rudser; Umesh Goswami; Marshall I Hertz; Jagadish Patil; Irena Cich; Sara J Shumway; Gabriel Loor
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

5.  Morbidity and mortality after general surgery in heart and lung transplant patients.

Authors:  Alek Zywot; Amber L Turner; Joanna Sesti; Russell C Langan; Andrew Nguyen; Andreas R de Biasi; Siva Raja; Usman Ahmad; Subroto Paul
Journal:  Surg Open Sci       Date:  2020-01-11

6.  Subclinical peritonitis due to perforated sigmoid diverticulitis 14 years after heart-lung transplantation.

Authors:  Haridimos Markogiannakis; Manousos Konstadoulakis; Dimitrios Tzertzemelis; Pantelis Antonakis; Ilias Gomatos; Constantinos Bramis; Andreas Manouras
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.